[In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]
oleh: Matteo Ferrario, Giovanni Giuliani
| Format: | Article |
|---|---|
| Diterbitkan: | SEEd Medical Publishers 2017-09-01 |
Deskripsi
No description available for this item.